OIG - Office of Inspector General
03/16/2026 | Press release | Distributed by Public on 03/16/2026 11:50
U.S. Attorney Announces Additional Enforcement Action as Part of National Effort to Combat Electrical Stimulation Fraud Scheme and Recover Millions
U.S. Attorney Announces Additional Enforcement Action as Part of National Effort to Combat Electrical Stimulation Fraud Scheme and Recover Millions
PHILADELPHIA - United States Attorney David Metcalf announced the filing of a complaint under the False Claims Act in the Eastern District of Pennsylvania. This is the latest action in the national investigation into the scheme of improper billing using the RST-Sanexas neoGEN-series electric stimulation device. Federal healthcare programs do not reimburse for electrical nerve stimulation treatments furnished in outpatient clinics to treat pain, nor do they cover vitamin injections used in conjunction with such treatments. As detailed below, this District and others have pursued and settled various False Claims Act cases against electrical stimulation providers, recovering millions.
Read more on https://www.justice.gov
Action Details
- Date:March 16, 2026
- Agency:U.S. Attorney's Office, Eastern District of Pennsylvania
-
Enforcement Types:
- Criminal and Civil Actions
OIG - Office of Inspector General published this content on March 16, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 16, 2026 at 17:50 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]